STOCK TITAN
  1. Home
  2. Sec-filings
  3. EQ
  4. [EFFECT] Equillium, Inc. SEC Filing

[EFFECT] Equillium, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 25, 2026 4:01 P.M.
Form: S-3
CIK: 0001746466
Company Name: Equillium, Inc.
File Number: 333-291510

Source: View Original Filing on SEC EDGAR

Equillium

NASDAQ:EQ

View EQ Stock Overview →

EQ Rankings

#4923 Ranked by Market Cap
N/A Ranked by Dividends

EQ Latest News

Mar 25, 2026
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights
Mar 18, 2026
Equillium to Participate in the 38th Annual Roth Conference
Mar 13, 2026
Equillium Announces $35 Million Financing with RA Capital Management
Feb 25, 2026
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference
Feb 2, 2026
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EQ Latest SEC Filings

Mar 25, 2026
[10-K] Equillium, Inc. Files Annual Report
Mar 25, 2026
[8-K] Equillium, Inc. Reports Material Event
Mar 20, 2026
[SCHEDULE 13G] Equillium, Inc. Passive Investment Disclosure (>5%)
Mar 16, 2026
[Form 4] Equillium, Inc. Insider Trading Activity
Mar 13, 2026
[144] Equillium, Inc. SEC Filing

EQ Stock Data

118.74M
48.11M
Biotechnology
Pharmaceutical Preparations
Link
United States
LA JOLLA